Pfizer (PFE) turned over within the red zone as forecast, but there is some bullish power in the short term tha we believe will push prices back up for another test of bearish resolve…

Apple Inc (AAPL) is behaving exactly as forecast…it is basing as bearish energy is being built up, and we forecast that there will be one more bullish “push” which will fail and this will likely be the catalyst to trigger more serious selling for the stock.

The Eurodollar vs. The U.S. Dollar (EUR/USD) is likely to reach down into areas of support, but at this time the odds for where it is likely to reverse is muddy. For this reason, we are establishing our coverage of this market with only a two diamond rating…

The S&P 500 index proxy (SPY) is showing a broad topping pattern, and we are forecasting that this will produce a lower high and at least a retest of the range lows near $204 per share. Once that level is tested, we will have new measurements with which to forecast whether a breakdown or the…

Pfizer (PFE) turned over within the red zone as forecast, but there is some bullish power in the short term tha we believe will push prices back up for another test of bearish resolve…

Apple Inc (AAPL) has stalled out after a huge rally. The stock has held steady, but now we see a correction beginning to form. We would expect to see this stock base sideways or show some mild bullish action, reaching back up into the red zone before beginning an acceleration to the downside.

The Eurodollar vs. The U.S. Dollar (EUR/USD) is likely to reach down into areas of support, but at this time the odds for where it is likely to reverse is muddy. For this reason, we are establishing our coverage of this market with only a two diamond rating…

Our outlook for gold is very uncertain as this market is quite dull and lacking energy. We have a slight short term bullish bias, which could take this market up to the $1,160 area, but we measure the odds at only 60/40 at this time. We will continue to follow this market if the intensity…

The S&P 500 index proxy (SPY) is showing a broad topping pattern, and we are forecasting that this will produce a lower high and at least a retest of the range lows near $204 per share. Once that level is tested, we will have new measurements with which to forecast whether a breakdown or the…

Pfizer (PFE) has been quite bullish for some time, and is showing signs of building a major top. We forecast a reversal of trend in this stock, and would have as a profit objective for short positions the bullish liquidity pool we see near $32.00 per share.